Slingsby Brian Taylor

CIK 00019639011 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001963901

Recent Transactions

22 trades

Award
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19+6,200→ 6,200 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19+8,300→ 8,300 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19−8,300→ 0 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19+8,300→ 8,300 total
Other
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19+6,200→ 7,910,038 total
Other
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19−6,200→ 0 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-20$43.35/sh−1,000,000→ 7,903,838 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-03-13$13.50/sh+259,259→ 8,903,838 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13−32,900→ 0 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13+32,900→ 32,900 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13+32,900→ 32,900 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-07-24$13.05/sh−550,000→ 8,644,579 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-05-22+22,000→ 22,000 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-05-22+22,000→ 22,000 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-05-22−22,000→ 0 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-07-12−44,000→ 0 total
Other
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-07-12+88,000→ 88,000 total
Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-02-14+4,314,093→ 8,944,579 total
Conversion
Mineralys Therapeutics, Inc.$MLYS
Series B Preferred Stock
2023-02-14−2,142,751→ 0 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-02-14$16.00/sh+250,000→ 9,194,579 total
Conversion
Mineralys Therapeutics, Inc.$MLYS
Series A Preferred Stock
2023-02-14−2,171,342→ 0 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-02-09+44,000→ 44,000 total

Companies

Mineralys Therapeutics, Inc.
Director, 10% Owner
$MLYS

Recent Filings

Address

1700 WESTLAKE AVE. N, SUITE 200 THINKSPACE

SEATTLE, WA, 98109

View on SEC.gov